Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Total Liabilities : ¥2,019 Mil (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Henan Taloph Pharmaceutical Stock Co Total Liabilities?

Henan Taloph Pharmaceutical Stock Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥2,019 Mil.

Henan Taloph Pharmaceutical Stock Co's quarterly Total Liabilities increased from Sep. 2023 (¥1,847.35 Mil) to Dec. 2023 (¥1,953.47 Mil) and increased from Dec. 2023 (¥1,953.47 Mil) to Mar. 2024 (¥2,019.00 Mil).

Henan Taloph Pharmaceutical Stock Co's annual Total Liabilities declined from Dec. 2021 (¥2,006.14 Mil) to Dec. 2022 (¥1,992.56 Mil) and declined from Dec. 2022 (¥1,992.56 Mil) to Dec. 2023 (¥1,953.47 Mil).

Henan Taloph Pharmaceutical Stock Co Total Liabilities Historical Data

The historical data trend for Henan Taloph Pharmaceutical Stock Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Taloph Pharmaceutical Stock Co Total Liabilities Chart

Henan Taloph Pharmaceutical Stock Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,503.34

1,904.14

2,006.14

1,992.56

1,953.47

Henan Taloph Pharmaceutical Stock Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,975.92	1,937.40	1,847.35	1,953.47	2,019.00

Henan Taloph Pharmaceutical Stock Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Henan Taloph Pharmaceutical Stock Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1650.148	+	(203.086	+	100.232
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,953

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3576.855	-	1623.389
	=	1,953

Henan Taloph Pharmaceutical Stock Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1735.561	+	(184.64	+	98.802
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,019

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	3652.922	-	1633.919
	=	2,019

Henan Taloph Pharmaceutical Stock Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001

Website

http://www.taloph.com

Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.

Executives

Zhao Qing Xin

Director

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Headlines

No Headlines